Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Change in Receivables (2010 - 2026)

Omnicell's (OMCL) quarterly Change in Receivables came in at -$23.1 million in Q2 2026, down 13.73% year-over-year from -$26.8 million in Q2 2025, and down 169.39% quarter-over-quarter from $33.3 million in Q1 2026.

Analysis

Omnicell (OMCL) Change in Receivables (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Change in Receivables for 17 consecutive years, with -$23.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Receivables fell 13.73% year-over-year to -$23.1 million in Q2 2026; TTM through Jun 2026 was -$5.4 million, a 46.12% increase from a year earlier, with the FY2025 full-year figure at -$41.4 million, down 928.15% from the prior year.
  • Change in Receivables was -$23.1 million for Q2 2026 at Omnicell, down from $33.3 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $50.0 million in Q1 2022 and troughed at -$56.5 million in Q4 2022.
  • A 5-year average of -$834555.6 and a median of -$2.0 million in 2023 frame the typical range for Change in Receivables.
  • Across the five-year window, Change in Receivables tumbled 4104.11% in 2022 and surged 1756.56% in 2024, its largest moves.
  • Over 5 years, Change in Receivables stood at -$56.5 million in 2022, then soared by 60.91% to -$22.1 million in 2023, then jumped by 127.95% to $6.2 million in 2024, then slumped by 569.14% to -$29.0 million in 2025, then increased by 20.25% to -$23.1 million in 2026.
  • The last three Change in Receivables figures came in at -$23.1 million (Q2 2026), $33.3 million (Q1 2026), and -$29.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 386.00 Mn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 74.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -224.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 177.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 46.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 10.20 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 172.10 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 37.21 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn -23.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.11 Mn
Mar 31, 2026 33.30 Mn
Dec 31, 2025 -28.97 Mn
Sep 30, 2025 13.41 Mn
Jun 30, 2025 -20.32 Mn
Mar 31, 2025 -5.55 Mn
Dec 31, 2024 6.18 Mn
Sep 30, 2024 9.72 Mn
Jun 30, 2024 -7.51 Mn
Mar 31, 2024 -3.39 Mn
Dec 31, 2023 -22.10 Mn
Sep 30, 2023 -587,000.00
Jun 30, 2023 -48.62 Mn
Mar 31, 2023 22.16 Mn
Dec 31, 2022 -56.54 Mn
Sep 30, 2022 45.48 Mn
Jun 30, 2022 21.42 Mn
Mar 31, 2022 49.99 Mn
Dec 31, 2021 1.41 Mn
Sep 30, 2021 19.90 Mn